ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

PBS Runs Misleading Lung Screening Claim; Reporter and Subject on Mount Sinai Faculty

October 11, 2013

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993

In the Cancer Centers: Rosen Moves To City Of Hope

November 1, 2013

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

BRMP Workshops Planned; DCT Board Balk At Size of Intramural Budget

November 28, 1980